Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
02/15/2011 | US7887794 Lactic acid bacteria and their use in the treatment of cancer |
02/15/2011 | CA2433071C Use of transcription factor yb-1 in adenoviral systems |
02/15/2011 | CA2406930C Preparation of aqueous clear solution dosage forms with bile acids |
02/15/2011 | CA2354046C New cancer treatments |
02/15/2011 | CA2353544C Preparation that contains oligosaccharides and probiotics |
02/10/2011 | WO2011017404A2 Retroelements and mental disorders and methods of measuring l1 retrotransposition |
02/10/2011 | WO2011017354A1 Composition and method for oral delivery of cobra venom |
02/10/2011 | WO2011017151A2 Pairing processes for preparing alloreactive cytotoxic t cells |
02/10/2011 | WO2011017143A2 Compositions and methods of preparing alloreactive cytotoxic t cells |
02/10/2011 | WO2011017040A1 Nutritional compositions comprising fiber and probiotics |
02/10/2011 | WO2011016812A1 Topical medicament for the treatment of psoriasis |
02/10/2011 | WO2011016527A1 Hydroxyl radical generator, antiviral material using hydroxyl radical generator, and method for generating hydroxyl radicals |
02/10/2011 | WO2011016070A1 Nutraceutical compositions containing probiotics in an oily vehicle |
02/10/2011 | WO2011015862A1 Cell support comprising dermal fibroblasts |
02/10/2011 | WO2011015614A1 A vaccine directed against porcine pleuropneumonia and a method to obtain such a vaccine |
02/10/2011 | WO2011015509A1 Food formulation comprising glycogen |
02/10/2011 | WO2010146405A3 Bee bread composition for prevention of ccd in honey-bees |
02/10/2011 | WO2010138024A3 Agent for protecting brain cells |
02/10/2011 | WO2010124837A3 Encapsulated liver cell composition |
02/10/2011 | WO2009111396A9 Dendritic cell precursor populations, dendritic cell populations derived therefrom and uses thereof |
02/10/2011 | US20110034867 Microthread delivery system |
02/10/2011 | US20110034377 Exendin and Exendin Agonists for Eating Disorders |
02/10/2011 | US20110033593 Preparation of oyster flesh extracts |
02/10/2011 | US20110033567 Preparation Comprising Mycobacterium Bovis BCG Killed by Extended Freeze Drying (EFD) for Preventing or Treating Rheumatoid Arthritis |
02/10/2011 | US20110033556 Natural Pharmaceutical Preparations for Increasing Albumin |
02/10/2011 | US20110033554 Method of Viral Inactivation of Biological Fluids |
02/10/2011 | US20110033525 Diterpene Glycosides as Natural Solubilizers |
02/10/2011 | US20110033504 Articles and methods for repairing damaged nervous tissue |
02/10/2011 | US20110033500 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb-neisseria meningitidis |
02/10/2011 | US20110033488 Agents and methods for treatment of anxiety disorders |
02/10/2011 | US20110033481 Prospective identification and characterization of breast cancer stem cells |
02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
02/10/2011 | US20110033435 Composition of activated CD4 cells |
02/10/2011 | US20110033434 Cultured three-dimensional tissues and uses thereof |
02/10/2011 | US20110033431 Type a2 botulinum toxin preparation |
02/10/2011 | US20110033430 Methods for the induction of a cell to enter the islet 1+ lineage and a method for the expansion thereof |
02/10/2011 | US20110033429 Inducible Gene Expression |
02/10/2011 | US20110033428 Method for isolating smooth muscle stem cells |
02/10/2011 | US20110033427 Expansion Of Renewable Stem Cell Populations |
02/10/2011 | US20110033426 Use of modified cells for the treatment of multiple sclerosis |
02/10/2011 | US20110033425 Parvovirus Having a CPG-Enriched Genome Useful for Cancer Therapy |
02/10/2011 | US20110033424 Use of adenovirus and nucleic acids coding therefor |
02/10/2011 | US20110033423 Probiotics for use in relieving symptoms associated with gastrointestinal disorders |
02/10/2011 | US20110033421 Methods related to immunostimulatory nucleic acid-induced interferon |
02/10/2011 | US20110033419 Methods and Compositions for Treating Cancer |
02/10/2011 | US20110033415 Agent for differentiating hematopoietic stem cell into natural killer cell comprising yc-1 or il-2 1 and a method of differentiating hematopoietic stem cell into natural killer cell using the same |
02/10/2011 | US20110033414 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
02/10/2011 | US20110033384 Chimeric polypeptides and their use |
02/10/2011 | CA2806790A1 Composition and method for oral delivery of cobra venom |
02/10/2011 | CA2772326A1 Pairing processes for preparing alloreactive cytotoxic t cells |
02/10/2011 | CA2772280A1 Compositions and methods of preparing alloreactive cytotoxic t cells |
02/10/2011 | CA2769323A1 Nutritional compositions comprising fiber and probiotics |
02/10/2011 | CA2760177A1 Food formulation comprising glycogen |
02/09/2011 | EP2281897A2 Oncolytic mutant Herpes Simplex virus |
02/09/2011 | EP2281884A1 Mesothelioma-specific promoter and use thereof |
02/09/2011 | EP2281871A1 Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
02/09/2011 | EP2281835A2 Anti-bacterial vaccine compositions |
02/09/2011 | EP2281834A2 Anti-bacterial vaccine compositions |
02/09/2011 | EP2281833A2 Anti-bacterial vaccine compositions |
02/09/2011 | EP2281832A2 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
02/09/2011 | EP2281588A1 Semi-synthetic platelet gel and method for the preparation thereof |
02/09/2011 | EP2281567A1 Inhibitor for blood phosphorus level elevation |
02/09/2011 | EP2281031A2 Methods and compositions for accelerating the generation of regulatory tcells ex vivo |
02/09/2011 | EP2280741A1 Irreversible electroporation to create tissue scaffolds |
02/09/2011 | EP2280726A1 Anti-viral nutraceutical |
02/09/2011 | EP2280719A2 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy |
02/09/2011 | EP2280717A1 Therapeutic agent for anaerobic diseases |
02/09/2011 | EP2280716A1 Agents and methods for treatment of anxiety disorders |
02/09/2011 | EP2280713A1 Methods and kits for the treatment of inflammatory bowel disorder conditions |
02/09/2011 | EP2280684A1 Composition for hair, skin and nail health maintenance |
02/09/2011 | EP2280612A1 Method for maintaining intestial bacteria in balance |
02/09/2011 | EP1716869B1 Drug for preventing or treating heart diseases comprising cd9 gene |
02/09/2011 | EP1698320B1 Method for moisturizing the skin |
02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
02/09/2011 | EP0771324B2 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
02/09/2011 | CN1994325B Dog gallbladder powder and its application in medicine preparation |
02/09/2011 | CN101970645A Method for producing vaccinal viral strain of a virus of the reoviridae family |
02/09/2011 | CN101970052A Design and selection of medicaments that modulate the function and activity of interleukin 13 |
02/09/2011 | CN101969967A Agent for prevention of alcoholic hepatopathy |
02/09/2011 | CN101969966A Bifidobacterium for dust mite allergy |
02/09/2011 | CN101969965A Fertilized egg isolate and use thereof |
02/09/2011 | CN101969947A Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
02/09/2011 | CN101969792A Methods and compositions for the treatment of bone conditions |
02/09/2011 | CN101967187A Protein related to cell stress, and coding gene and application thereof |
02/09/2011 | CN101966329A Medicament for treating rash |
02/09/2011 | CN101966327A Chinese medicinal composition for treating recurrent menorrhea and preparation method thereof |
02/09/2011 | CN101966326A Health-care product for improving human immunity |
02/09/2011 | CN101966325A Medicament for treating damp-heat stasis blocking type endometriosis and preparation method thereof |
02/09/2011 | CN101966324A Chinese medicinal compound preparation for treating chronic hepatitis B liver fibrosis and preparation method thereof |
02/09/2011 | CN101966322A Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof |
02/09/2011 | CN101966321A Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof |
02/09/2011 | CN101966320A Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof |
02/09/2011 | CN101966319A Traditional Chinese medicinal composition for treating dizziness during menstruation and preparation method thereof |
02/09/2011 | CN101966318A Traditional Chinese medicinal composition for curing breast pain during menstruation and preparation method thereof |
02/09/2011 | CN101966317A Traditional Chinese medicine for treating hepatobiliary diseases of turtles |
02/09/2011 | CN101966315A Traditional Chinese medicine for treating bone injury |
02/09/2011 | CN101966314A Traditional Chinese medicine preparation for tonifying kidney and replenishing sperm and preparation method thereof |
02/09/2011 | CN101966313A Chinese medicinal composition for treating female infertility and preparation method thereof |